3-Nitrotyrosine, a biomarker for cardiomyocyte apoptosis induced by diabetic cardiomyopathy in a rat model

Molecular Medicine Reports

Volumn 8, Issue 4, 2013, Pages 989-994

  Zhang, Ya Li ^a   Wei, Jin Ru ^b  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b First People's Hospital of Nanning   (China)

Author keywords

3 nitrotyrosine; Apoptosis; Diabetic cardiomyopathy

Indexed keywords

3 NITROTYROSINE; STREPTOZOCIN; VALSARTAN; 3-NITROTYROSINE; BIOLOGICAL MARKER; TETRAZOLE DERIVATIVE; TYROSINE; VALINE;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; HEART; HEART MUSCLE CELL; HEART PROTECTION; HEART WEIGHT; HISTOPATHOLOGY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PREDICTIVE VALUE; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RANDOMIZATION; RAT; STREPTOZOCIN DIABETES; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; COMPLICATION; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; HEART MUSCLE; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC CARDIOMYOPATHIES; MALE; MYOCARDIUM; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; TETRAZOLES; TYROSINE; VALINE;

EID: 84883324518     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1644     Document Type: Article

References (19)

1. Bell DS: Diabetic cardiomyopathy. Diabetes Care 26: 2949-2951, 2003.
2. Dokken BB: The Pathophysiology of Cardiovascular Disease and Diabetes: Beyond Blood Pressure and Lipids. Diabetes Spectr 21: 160-165, 2008.
3. Cai L and Kang YJ: Oxidative stress and diabetic cardimyopathy: a brief review. Cardiovasc Toxicol 1: 181-193, 2001.
4. Aksakal E, Akaras N, Kurt M, et al: The role of oxidative stress in diabetic cardiomyopathy: an experimental study. Eur Rev Med Pharmacol Sci 15: 1241-1246, 2011.
5. Cai L and Kang YJ: Cell death and diabetic cardimyopathy. Cardiovasc Toxicol 3: 219-228, 2003.
6. Srinivasan K, Viswanad B, Asrat L, et al: Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res 52: 313-320, 2005.
7. Raviv G, Kiss R, Vanegas JP, et al: Objective measurement of the different collagen types in the corpus cavernosum of potent and impotent men: an immunohistochemical staining with computerized-image analysis. World J Urol 15: 50-55, 1997.
8. Tillquist MN and Maddox TM: Update on diabetic cardiomyopathy: inches forward, miles to go. Curr Diab Rep 12: 305-313, 2012.
9. Rubler S, Dlugash J, Yuceoglu YZ, et al: New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 30: 595-602, 1972.
10. Hamby RI, Zoneraich S and Sherman L: Diabetic cardiomyopathy. JAMA 229: 1749-1754, 1974.
11. Ceriello A: The hyperglycemia-induced metabolic memory: the new challenge for the prevention of CVD in diabetes. Rev Esp Cardiol 8 (Suppl C): 11-17, 2008.
12. Kowluru RA: Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. Diabetes 52: 818-823, 2003.
13. Turko IV and Murad F: Protein nitration in cardiovascular diseases. Pharmacol Rev 54: 619-634, 2002.
14. Singh VP, Le B, Khode R, et al: Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis. Diabetes 57: 3297-3306, 2008.
15. Zhou G, Li X, Hein DW, et al: Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart. J Am Coll Cardiol 52: 655-666, 2008.
16. Cai L, Wang Y, Zhou G, et al: Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy. J Am Coll Cardiol 48: 1688-1697, 2006.
17. Mason RM and Wahab NA: Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol 14: 1358-1373, 2003.
18. Ceriello A, Mercuri F, Quagliaro L, et al: Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologia 44: 834-838, 2001.
19. Ceriello A, Assaloni R, Da Ros R, et al: Effect of irbesartan on nitrotyrosine generation in non-hypertensive diabetic patients. Diabetologia 47: 1535-1540, 2004.